Horn J R, Zierler B, Bauer L A, Reiss W, Strandness D E
Department of Pharmacy Practice, School of Pharmacy, University of Washington, Seattle 98195.
J Clin Pharmacol. 1990 Oct;30(10):922-9. doi: 10.1002/j.1552-4604.1990.tb03572.x.
The measurement of hepatic blood flow by indirect methods such as indocyanine green clearance has several limitations. The duplex Doppler offers the potential for noninvasive, real-time measurement of blood flow and has been employed in the evaluation of arterial disease in a variety of vascular beds. We evaluated Doppler ultrasound estimation of blood flow in branches of the hepatic artery, hepatic vein, and portal vein in 12 healthy subjects on two separate days. In vitro accuracy of the scanner was assessed using phantom targets of known diameter and velocity. Blood velocity and vessel diameter measurements were obtained five times over a period of 2 hours. No significant differences were seen in velocity or blood flow measurements within or between days. The interday coefficients of variation, which include intrasubject variability, were 10-15% and 14-20% for velocity and blood flow measurements, respectively. This study demonstrates the potential utility of Doppler ultrasound to detect intrinsic, drug, or disease-induced changes in hepatic blood flow.
通过间接方法(如吲哚菁绿清除率)测量肝血流存在一些局限性。双功多普勒为无创、实时测量血流提供了可能,并已用于评估各种血管床的动脉疾病。我们在两天内对12名健康受试者的肝动脉、肝静脉和门静脉分支的血流进行了多普勒超声评估。使用已知直径和速度的模拟靶标评估扫描仪的体外准确性。在2小时内对血流速度和血管直径进行了5次测量。日内或日间的速度或血流测量均未发现显著差异。包括受试者内变异性的日间变异系数,血流速度测量为10%-15%,血流测量为14%-20%。本研究证明了多普勒超声检测肝血流内在、药物或疾病引起变化的潜在效用。